zedie.wordpress.com
Has pancreatic damage from glucagon suppressing diabetes drugs been underplayed?.
Incretin mimetics have been called “the darlings of diabetes treatment” and they may soon also be licensed for treating obesity. But a BMJ investigation has found growing safety concerns linked to …